Report for: Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment

Title	Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Published in	PLOS ONE, October 2012
DOI	10.1371/journal.pone.0047905
Pubmed ID	23112868
Authors	Liyong Wu, Jared Rowley, Sara Mohades, Antoine Leuzy, Marina Tedeschi Dauar, Monica Shin, Vladimir Fonov, Jianping Jia, Serge Gauthier, Pedro Rosa-Neto, the Alzheimer’s Disease Neuroimaging Initiative
Abstract	The hypothetical model of dynamic biomarkers for Alzheimer's disease (AD) describes high amyloid deposition and hypometabolism at the mild cognitive impairment (MCI) stage. However, it remains unknown whether brain amyloidosis and hypometabolism follow the same trajectories in MCI individuals. We used the concept of early MCI (EMCI) and late MCI (LMCI) as defined by the Alzheimer's disease Neuroimaging Initiative (ADNI)-Go in order to compare the biomarker profile between EMCI and LMCI.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Egypt	1	50%
United States	1	50%

Type	Count	As %
Practitioners (doctors, other healthcare professionals)	1	50%
Scientists	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Master	12	15%
Researcher	10	13%
Student > Ph. D. Student	9	11%
Professor	7	9%
Student > Bachelor	6	8%
Other	19	24%
Unknown	17	21%

Readers by discipline	Count	As %
Neuroscience	12	15%
Medicine and Dentistry	11	14%
Psychology	10	13%
Agricultural and Biological Sciences	4	5%
Biochemistry, Genetics and Molecular Biology	3	4%
Other	12	15%
Unknown	28	35%

PLOS